NSN 6505-01-228-0009
Part Details | USP CEFTAZIDIME FOR INJECTION
6505-01-228-0009
Alternate Parts: NDC24987037934, NDC24987-0379-34, NDC00409508411, NDC00409-5084-11, NDC00781317895, NDC00781-3178-95, 6505-01-228-0009, 01-228-0009, 6505012280009, 012280009
Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
---|---|---|---|
65 | MAR 13, 1986 | 01-228-0009 | 42844 ( CEFTAZIDIME FOR INJECTION, USP ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-228-0009
Part Number | Cage Code | Manufacturer |
---|---|---|
NDC24987-0379-34 | 6NK74 | COVIS PHARMACEUTICALS, INC. |
NDC00409-5084-11 | 3VBU6 | HOSPIRA, INC. |
NDC00781-3178-95 | 04520 | NOVARTIS PHARMACEUTICALS CORPORATIONDBA NPS |
Technical Data | NSN 6505-01-228-0009
Characteristic | Specifications |
---|---|
ACTIVE MEDICAMENT MEDICINAL STRENGTH | BZ2.000 GRAMS CEFTAZIDIME, ANHYDROUS |
PHYSICAL FORM | POWDER |
PRIMARY CONTAINER TYPE | VIAL |
PRIMARY CONTAINER CONTENT QUANTITY | 2.000 GRAMS OF ACTIVE INGREDIENT |
TOTAL PRIMARY CONTAINER QUANTITY | 10 |
SECONDARY CONTAINER TYPE | PACKAGE |
FEATURES PROVIDED | STERILE |
SPECIAL FEATURES | EACH VIAL CONTAINS CEFTAZIDIME PENTAHYDRATE EQUIVALENT TO 2 GRAMS OF CEFTATAZIDIME AND 118 MILLIGRAMS SODIUM CARBONATE PER GRAM OF CEFTAZIDIME |
PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
PART NAME ASSIGNED BY CONTROLLING AGENCY | CEFTAZIDIME FOR INJECTION USP 2GM VIAL 10S |